AOD 9604 was created as a potential treatment for obesity, providing the same fat-burning effects as HGH metabolism without effecting serum glucose or IGF-1 levels
[1] [6] Severe deficiencies may include symptoms of reduced heart function, suppression of bone marrow, as well as more various severe neurological symptoms possibly including sensory loss, abnormal balance and reflexes, memory and consciousness impairment, smell and taste problems, depression, irritability, confusion, and psychosis
13 There is a pressing need to establish the true prevalence of IDA in pregnancy within Australia and identify subgroups of women, such as Aboriginal and Torres Strait Islander women, who are particularly vulnerable and for whom we can target treatment and preventive strategies
(Agnoli et al., 2017
All vials contain 0.9% benzyl alcohol as a bacteriostatic preservative and are intended for diluting or dissolving medications for injection
The evidence summary below is compound-level only